AR109846A1 - Validación de aclaramiento viral continuo - Google Patents
Validación de aclaramiento viral continuoInfo
- Publication number
- AR109846A1 AR109846A1 ARP170102921A ARP170102921A AR109846A1 AR 109846 A1 AR109846 A1 AR 109846A1 AR P170102921 A ARP170102921 A AR P170102921A AR P170102921 A ARP170102921 A AR P170102921A AR 109846 A1 AR109846 A1 AR 109846A1
- Authority
- AR
- Argentina
- Prior art keywords
- validation
- viral clearance
- probe
- continuous viral
- continuous
- Prior art date
Links
- 238000010200 validation analysis Methods 0.000 title abstract 3
- 230000003612 virological effect Effects 0.000 title abstract 3
- 239000000523 sample Substances 0.000 abstract 5
- 241000700605 Viruses Species 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 1
- 238000005070 sampling Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/22—Testing for sterility conditions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
- A61L2/0029—Radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
- A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16194959.9A EP3141611A3 (en) | 2016-10-21 | 2016-10-21 | Validation of continuous viral clearance |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR109846A1 true AR109846A1 (es) | 2019-01-30 |
Family
ID=57209212
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP170102921A AR109846A1 (es) | 2016-10-21 | 2017-10-20 | Validación de aclaramiento viral continuo |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US10894991B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP3141611A3 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2019537435A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20190066017A (cg-RX-API-DMAC7.html) |
| CN (1) | CN110100008A (cg-RX-API-DMAC7.html) |
| AR (1) | AR109846A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2017345412A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112019007835A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3041253A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL266095A (cg-RX-API-DMAC7.html) |
| MX (1) | MX385466B (cg-RX-API-DMAC7.html) |
| RU (1) | RU2755634C2 (cg-RX-API-DMAC7.html) |
| SG (1) | SG10202104023QA (cg-RX-API-DMAC7.html) |
| TW (1) | TW201827830A (cg-RX-API-DMAC7.html) |
| UY (1) | UY37447A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2018075716A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019011900A1 (en) * | 2017-07-10 | 2019-01-17 | Baxalta Incorporated | METHOD FOR LIQUID INCUBATION AND VIRUS INACTIVATION |
| EP4112735A4 (en) * | 2020-02-28 | 2023-09-06 | Asahi Kasei Medical Co., Ltd. | Method for evaluating viral clearance performance |
| CN116261566A (zh) * | 2020-09-21 | 2023-06-13 | 拜耳医药保健有限责任公司 | 病原体清除系统和方法 |
| US12203914B2 (en) * | 2020-11-12 | 2025-01-21 | Sartorius Bioanalytical Instruments, Inc. | Viral clearance evaluation for biological medical product preparation processes |
| EP4317460B1 (en) * | 2021-03-26 | 2025-12-31 | Asahi Kasei Life Science Corporation | VIRAL CLEARANCE TEST PROCEDURE |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG184833A1 (en) * | 2010-04-14 | 2012-11-29 | Emd Millipore Corp | Methods of producing high titer, high purity virus stocks and methods of use thereof |
| AU2014100888A4 (en) * | 2014-08-07 | 2014-09-11 | Novartis Ag | Virus clearance and protein purification methods |
-
2016
- 2016-10-21 EP EP16194959.9A patent/EP3141611A3/en not_active Withdrawn
-
2017
- 2017-10-19 JP JP2019520956A patent/JP2019537435A/ja not_active Ceased
- 2017-10-19 MX MX2019004540A patent/MX385466B/es unknown
- 2017-10-19 BR BR112019007835A patent/BR112019007835A2/pt not_active IP Right Cessation
- 2017-10-19 TW TW106135849A patent/TW201827830A/zh unknown
- 2017-10-19 CN CN201780064932.4A patent/CN110100008A/zh active Pending
- 2017-10-19 KR KR1020197010823A patent/KR20190066017A/ko not_active Ceased
- 2017-10-19 WO PCT/US2017/057298 patent/WO2018075716A1/en not_active Ceased
- 2017-10-19 AU AU2017345412A patent/AU2017345412A1/en not_active Abandoned
- 2017-10-19 RU RU2019115375A patent/RU2755634C2/ru active
- 2017-10-19 SG SG10202104023QA patent/SG10202104023QA/en unknown
- 2017-10-19 CA CA3041253A patent/CA3041253A1/en not_active Abandoned
- 2017-10-19 EP EP17791896.8A patent/EP3529367A1/en not_active Withdrawn
- 2017-10-20 UY UY0001037447A patent/UY37447A/es not_active Application Discontinuation
- 2017-10-20 US US16/343,125 patent/US10894991B2/en not_active Expired - Fee Related
- 2017-10-20 AR ARP170102921A patent/AR109846A1/es not_active Application Discontinuation
-
2019
- 2019-04-17 IL IL266095A patent/IL266095A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN110100008A (zh) | 2019-08-06 |
| EP3529367A1 (en) | 2019-08-28 |
| AU2017345412A1 (en) | 2019-04-18 |
| MX2019004540A (es) | 2019-06-12 |
| IL266095A (en) | 2019-06-30 |
| CA3041253A1 (en) | 2018-04-26 |
| RU2755634C2 (ru) | 2021-09-17 |
| US20190316213A1 (en) | 2019-10-17 |
| KR20190066017A (ko) | 2019-06-12 |
| JP2019537435A (ja) | 2019-12-26 |
| WO2018075716A1 (en) | 2018-04-26 |
| RU2019115375A3 (cg-RX-API-DMAC7.html) | 2021-03-19 |
| SG10202104023QA (en) | 2021-06-29 |
| MX385466B (es) | 2025-03-18 |
| EP3141611A2 (en) | 2017-03-15 |
| US10894991B2 (en) | 2021-01-19 |
| BR112019007835A2 (pt) | 2019-10-01 |
| UY37447A (es) | 2018-05-31 |
| EP3141611A3 (en) | 2017-05-10 |
| RU2019115375A (ru) | 2020-11-23 |
| TW201827830A (zh) | 2018-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR109846A1 (es) | Validación de aclaramiento viral continuo | |
| CL2019000278A1 (es) | Agentes rnai para infección con virus de hepatitis b. | |
| IL279706A (en) | Scanning electron microscope and methods of inspecting and reviewing samples | |
| IL280559A (en) | Hepatitis b virus (hbv) dsrna agent compositions and methods of use thereof | |
| CL2014002551A1 (es) | Metodo para identificar segmento de audio, que comprende las etapas de crear un espectrograma del segmento candidato de audio, crear un mapa candidato de bits huella digital y acustica del espectrograma, comparar el mapa candidato con al menos un mapa conocido de un mensaje de red conocido, si el mapa candidato coincide con un mapa conocido, declarar el calce, y si el candidato no coincide, utilizar un algoritmo de deteccion para analizar el segmento de audio candidato; metodos asociados. | |
| IL256644B (en) | System and method for management, execution, and analysis of laboratory experiments | |
| CO2017003490A2 (es) | Moléculas de anticuerpos a pd-l1 | |
| DK3643795T3 (da) | Fremganffremgangsmåde til bestemmelse af celle- eller vævsdød ved analyse af dna-methylering | |
| CL2015003608A1 (es) | Evento transgénico de soja mon87751 y métodos para su detección y uso. | |
| BR112015015975A2 (pt) | moléculas de dsrna isoladas e métodos de uso das mesmas para silenciamento das moléculas alvo de interesse. | |
| DK3224755T3 (da) | Statistisk analysefremgangsmåde til bestemmelse af risiko ved filbaseret indhold | |
| MA52506A (fr) | Procédés de traitement d'infections par des virus nipah | |
| DK3194612T3 (da) | Fremgangsmåder til kvantitativ genetisk analyse af cellefrit dna | |
| EP3414650A4 (en) | SOCIAL KEYBOARD | |
| MX2017005888A (es) | Dispositivos, sistemas y metodos para la deteccion de analitos. | |
| PE20180171A1 (es) | Neutralizacion del virus chikungunya mediada por anticuerpos | |
| IL271147A (en) | Methods for accurate computational decomposition of dna mixtures from contributors of unknown genotypes | |
| EP3630732A4 (en) | Method and molecules | |
| MX2016013877A (es) | Composiciones y metodos para mejorar y/o predecir la amplificacion de adn. | |
| NI201600147A (es) | Métodos y aparato para la coordinación de la selección del sistema entre un conjunto de nodos | |
| MX2017003635A (es) | Metodo para medir la reactividad del factor de coagulacion viii (fviii). | |
| EA201990730A1 (ru) | Рнк-биомаркеры для наследственного ангионевротического отека | |
| BR112018008757A2 (pt) | suspensor de liner | |
| EP3625349A4 (en) | MODIFIED VIRUSES | |
| DK3555313T3 (da) | Molekylær detektering ved hjælp af ligeringsamplifikation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |